Other recommendations of the Final report, including asking for assessment of inter-generational and chronic impacts, or the need for the regulatory regime to be open to new scientific information that may have a bearing on risk assessment even after deregulation of a product, or for India to establish a strong, state-of-the-art biosafety regulatory system are all most welcome and their implementa